ICH outlines quality requirements for developing and manufacturing drug substances
This article was originally published in SRA
Executive Summary
The International Conference on Harmonisation has finalised a guideline explaining quality-related requirements for developing and manufacturing drug substances, both chemical and biotechnological/biological entities1,2.